(Q37215570)

19 August 2017

1 reference

title

Insulin resistance and blood pressure (English)

1 reference

19 August 2017

1 reference

1 reference

Sonya Addison

1

1 reference

19 August 2017

Sameer Stas

series ordinal

2

1 reference

19 August 2017

Melvin R Hayden

series ordinal

3

1 reference

19 August 2017

James R Sowers

series ordinal

4

1 reference

19 August 2017

1 August 2008

1 reference

Current Hypertension Reports

19 August 2017

1 reference

19 August 2017

10

1 reference

19 August 2017

4

1 reference

19 August 2017

319-325

1 reference

https://scigraph.springernature.com/pub.10.1007/s11906-008-0059-1

19 August 2017

0 references

cites work

Metabolic safety of antihypertensive drugs: myth versus reality

1 reference

12 December 2020

Aldosterone and hypertension in the cardiometabolic syndrome

1 reference

12 December 2020

The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.

1 reference

12 December 2020

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Skeletal muscle insulin resistance is fundamental to the cardiometabolic syndrome

1 reference

12 December 2020

Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes

1 reference

12 December 2020

Effect of ramipril on the incidence of diabetes

1 reference

12 December 2020

The pathobiology of diabetic complications: a unifying mechanism

1 reference

12 December 2020

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

12 December 2020

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

12 December 2020

Insulin resistance and hypertension

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.

1 reference

12 December 2020

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

12 December 2020

Effect of exercise training on plasma levels of C-reactive protein in healthy adults: the HERITAGE Family Study

1 reference

12 December 2020

Adiponectin and insulin sensitivity in primary aldosteronism

1 reference

12 December 2020

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

1 reference

12 December 2020

Obesity and hypertension

1 reference

12 December 2020

Treatment of hypertension with thiazides: benefit or damage-effect of low- and high-dose thiazide diuretics on arterial elasticity and metabolic parameters in hypertensive patients with and without glucose intolerance.

1 reference

12 December 2020

Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.

1 reference

12 December 2020

Comparative effects of telmisartan and valsartan on insulin resistance in hypertensive patients with metabolic syndrome

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Glucose metabolism in patients with essential hypertension.

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Antihypertensive therapy with aliskiren

1 reference

12 December 2020

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

1 reference

12 December 2020

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

1 reference

12 December 2020

Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes

1 reference

12 December 2020

Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.

1 reference

12 December 2020

Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions

1 reference

12 December 2020

Antihypertensive medications and the risk of incident type 2 diabetes

1 reference

12 December 2020

Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

1 reference

12 December 2020

Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study.

1 reference

12 December 2020

Development of diabetes with thiazide diuretics: the potassium issue

1 reference

12 December 2020

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort

1 reference

12 December 2020

The effect of leisure-time physical activity on the presence of metabolic syndrome in patients with manifest arterial disease. The SMART study

1 reference

12 December 2020

PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin

1 reference

12 December 2020

10.1007/S11906-008-0059-1

Identifiers

DOI

1 reference

19 August 2017

1 reference